Xiaoguang Liu

14PUBLICATIONS
59CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)System and network securityCarbon capture engineering (excl. sequestration)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 25, 2025
PSAT1 impairs ferroptosis and reduces immunotherapy efficacy via GPX4 hydroxylation.

Peixiang Zheng, Zhiqiang Hu, Yuli Shen

|Mar 29, 2024
BRCA1-Mediated Dual Regulation of Ferroptosis Exposes a Vulnerability to GPX4 and PARP Co-Inhibition in BRCA1-Deficient Cancers.

Guang Lei, Chao Mao, Amber D Horbath

|Mar 02, 2024
Proteomic analysis of ferroptosis pathways reveals a role of CEPT1 in suppressing ferroptosis.

Xiaoguang Liu, Zhen Chen, Yuelong Yan

|Jan 03, 2024
Cell cycle arrest induces lipid droplet formation and confers ferroptosis resistance.

Hyemin Lee, Amber Horbath, Lavanya Kondiparthi

|Jul 05, 2023
Reply to: DHODH inhibitors sensitize to ferroptosis by FSP1 inhibition.

Chao Mao, Xiaoguang Liu, Yuelong Yan

|Jun 20, 2023
SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells.

Yuelong Yan, Hongqi Teng, Qinglei Hang

Pageof 3

Frequent Collaborators

12 joint publications

Boyi Gan

9 joint publications

Guang Lei

8 joint publications

Yuelong Yan

6 joint publications

Yilei Zhang